People · Operator
Named in public records as an officer, director or promoter · active 2009–2010 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Armune BioScience Inc | — | Biotechnology | Series A | $11.9M | $18.1M | 2009 |
James L. Sollins at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James L. Sollins on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Donald R. Parfet | 1 | 5 |
| Eli L. Thomssen | 1 | 3 |
| Gilbert Omenn | 1 | 1 |
| James Sollins | 1 | 1 |
| Dennis P. Kane | 1 | 1 |
| Gilbert L. Omenn | 1 | 1 |
| David A Esposito | 1 | 1 |
| Susan R Crookston | 1 | 1 |
| James R Sollins | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.